Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D McDermott

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Foodborne Pathogens and Disease|May 23, 2013
Retrospective analysis of Salmonella, Campylobacter, Escherichia coli, and Enterococcus in animal feed ingredientsBeilei Ge, Patricia C LaFon, Peggy J Carter, et al.
Frontiers in Oncology|July 30, 2025
Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer CenterAhmed Alsafar, Sama L Kareem, Bradley R Corr, et al.
Oral Oncology|December 26, 2015
A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinomaDaniel W Bowles, Stephen B Keysar, Justin R Eagles, et al.
Annals of the Royal College of Surgeons of England|February 28, 2015
Female gender and diabetes mellitus increase the risk of recurrence after laparoscopic incisional hernia repairS T Hornby, F D McDermott, M Coleman, et al.
ESMO Open|May 13, 2025
A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancerM A Gouda, M H Voss, H Tawbi, et al.
International Journal of Cancer|January 12, 2026
Outcomes from the English National Lynch Syndrome transformation projectKevin J Monahan, Paul Fleming, Neil A J Ryan, et al.
BMJ Oncology|January 31, 2025
The English National Lynch Syndrome transformation project: an NHS Genomic Medicine Service Alliance (GMSA) programmeKevin J Monahan, Neil Ryan, Laura Monje-Garcia, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path ForwardL C Harshman, C G Drake, N B Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic AlterationsKai Wang, Jeffery S Russell, Jessica D McDermott, et al.
Nature Cancer|November 26, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCCLaurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Foodborne Pathogens and Disease|May 23, 2013
Retrospective analysis of Salmonella, Campylobacter, Escherichia coli, and Enterococcus in animal feed ingredientsBeilei Ge, Patricia C LaFon, Peggy J Carter, et al.
Frontiers in Oncology|July 30, 2025
Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer CenterAhmed Alsafar, Sama L Kareem, Bradley R Corr, et al.
Oral Oncology|December 26, 2015
A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinomaDaniel W Bowles, Stephen B Keysar, Justin R Eagles, et al.
Annals of the Royal College of Surgeons of England|February 28, 2015
Female gender and diabetes mellitus increase the risk of recurrence after laparoscopic incisional hernia repairS T Hornby, F D McDermott, M Coleman, et al.
ESMO Open|May 13, 2025
A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancerM A Gouda, M H Voss, H Tawbi, et al.
International Journal of Cancer|January 12, 2026
Outcomes from the English National Lynch Syndrome transformation projectKevin J Monahan, Paul Fleming, Neil A J Ryan, et al.
BMJ Oncology|January 31, 2025
The English National Lynch Syndrome transformation project: an NHS Genomic Medicine Service Alliance (GMSA) programmeKevin J Monahan, Neil Ryan, Laura Monje-Garcia, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path ForwardL C Harshman, C G Drake, N B Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic AlterationsKai Wang, Jeffery S Russell, Jessica D McDermott, et al.
Nature Cancer|November 26, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCCLaurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
Pageof 25